This report investigates different options for using human papillomavirus (HPV) testing in cervical cancer prevention. These options are evaluated by a stochastic model of the progression of pre-malignancy and its relationship to HPV infection. Three screening policies are compared: 2 based on cytol
โฆ LIBER โฆ
Can breast and cervical cancer screening visits be used to enhance colorectal cancer screening?
โ Scribed by Carlos, Ruth C.; Fendrick, A. Mark; Ellis, James; Bernstein, Steven J.
- Book ID
- 122452715
- Publisher
- Elsevier Science
- Year
- 2004
- Tongue
- English
- Weight
- 111 KB
- Volume
- 1
- Category
- Article
- ISSN
- 1546-1440
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Can papilloma virus testing be used to i
โ
David Jenkins; Chris Sherlaw-Johnson; Steve Gallivan
๐
Article
๐
1996
๐
John Wiley and Sons
๐
French
โ 650 KB
PP31. The relative economics of screenin
โ
D Gvrd-Hansen
๐
Article
๐
1997
๐
Elsevier Science
๐
English
โ 327 KB
CAN HPV BE THE SOLE PRIMARY CERVICAL CAN
โ
J. Cuzick
๐
Article
๐
2006
๐
John Wiley and Sons
๐
English
โ 450 KB
Can prognostic factors be used to reduce
โ
N Harbeck
๐
Article
๐
2004
๐
Elsevier Science
๐
English
โ 178 KB
Can screening for cervical cancer be imp
โ
Anthony B. Miller; Rengaswamy Sankaranarayanan; F. Xavier Bosch; Cecilia Sepulve
๐
Article
๐
2003
๐
John Wiley and Sons
๐
French
โ 59 KB
A review : Obesity and screening for bre
โ
Sarah S. Cohen; Rachel T. Palmieri; Sarah J. Nyante; Daniel O. Koralek; Sangmi K
๐
Article
๐
2008
๐
John Wiley and Sons
๐
English
โ 130 KB
## Abstract The literature examining obesity as a barrier to screening for breast, cervical, and colorectal cancer has not been evaluated systematically. With the increasing prevalence of obesity and its impact on cancer incidence and mortality, it is important to determine whether obesity is a bar